Person Career

There is encouraging news about the results of a Phase 2 clinical trial on a new brain cancer vaccine.  All the patients in the trial have shown an immune response.  Researchers have also found that the vaccine is safe and less toxic than conventional treatments and that it could extend survival for people with recurrent glioblastoma.  The research was partially funded with matching grants by Accelerate Brain Cancer Cure, the National Institutes of Health, the American Brain Tumor Association and the National Brain Tumor Society.

Last week, a branch of the World Health Organization weighed in on the much debated question of a cell phone/brain cancer link.  The International Agency for Research into Cancer (IARC) announced that "radio frequency electromagnetic fields" - the type transmitted by by cell phones - as a "possible" cause of cancer in humans.

Accelerate Brain Cancer Cure and the Chordoma Foundation are co-hosting the 57th meeting of the National Cancer Institute Director's Consumer Liaison Group (DCLG) in Chapel Hill, North Carolina from May 18 - 20th.

Deck: 
American Idol David Cook Returns To Serve As Honorary Chair and Join Thousands in Race

Gaithersburg, MD - On March 17, 2011, the Food and Drug Administration's Neurological Devices Panel endorsed the premarket approval application (PMA) for Novocure's NovoTTF-100A Treatment Kit - a novel, non-invasive device that blasts glioblastoma brain tumors with an electrical field.

WEST PALM BEACH, FL - More than 800 runners and walkers joined forces on Sunday, March 6, 2022 for the 2nd Annual Florida Brain Cancer 5k Run/Walk, and together raised more than $146,000 to benefit brain cancer research projects and collaborations through Accelerate Brain Cancer Cure.

A University of Alabama at Birmingham study has identified a gene deletion in nearly 25 percent of all glioblastoma cases that is believed to be responsible for poor patient outcomes. The discovery could lead to better diagnosis and targeted treatments with drugs that are currently available.

Deck: 
Duke Vaccine Extends Life for Brain Cancer Patients

October 4, 2021 - A new vaccine added to standard therapy appears to offer a survival advantage for patients suffering from glioblastoma (GBM), the most deadly form of brain cancer, according to a study from researchers at Duke University Medical Center and The University of Texas MD Anderson Cancer Center.

The vaccine also knocks out a troublesome growth factor that characterizes the most aggressive form of the disease.

Pages

Share |

Join us in our fight for a cure!

Twitter